LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.80 | 21.74 | 1195 | 2381 | 0.5018 | 0.8065 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.77 | 21.74 | 1182 | 2602 | 0.4541 | 0.7839 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.77 | 21.74 | 1203 | 2602 | 0.4622 | 0.7885 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.77 | 21.74 | 1175 | 2602 | 0.4514 | 0.7824 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.77 | 21.74 | 1188 | 2602 | 0.4564 | 0.7852 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.74 | 21.74 | 1184 | 2828 | 0.4186 | 0.7668 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.74 | 21.74 | 1206 | 2828 | 0.4264 | 0.7714 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.74 | 21.74 | 1181 | 2828 | 0.4176 | 0.7662 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.74 | 21.74 | 1196 | 2828 | 0.4229 | 0.7693 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.71 | 21.74 | 1181 | 3084 | 0.3829 | 0.7487 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.71 | 21.74 | 1198 | 3084 | 0.3884 | 0.7522 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.71 | 21.74 | 1176 | 3084 | 0.3813 | 0.7477 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.71 | 21.74 | 1193 | 3084 | 0.3868 | 0.7512 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.68 | 21.74 | 1214 | 3418 | 0.3551 | 0.7354 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.68 | 21.74 | 1230 | 3418 | 0.3598 | 0.7386 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.68 | 21.74 | 1183 | 3418 | 0.3460 | 0.7293 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.68 | 21.74 | 1199 | 3418 | 0.3507 | 0.7325 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.65 | 21.74 | 1213 | 3754 | 0.3231 | 0.7180 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.65 | 21.74 | 1229 | 3754 | 0.3274 | 0.7210 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.65 | 21.74 | 1195 | 3754 | 0.3183 | 0.7145 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.65 | 21.74 | 1208 | 3754 | 0.3218 | 0.7170 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.62 | 21.74 | 1213 | 4150 | 0.2922 | 0.7003 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.62 | 21.74 | 1221 | 4150 | 0.2942 | 0.7017 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.62 | 21.74 | 1222 | 4150 | 0.2944 | 0.7019 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.62 | 21.74 | 1236 | 4150 | 0.2978 | 0.7045 | MN20160310_N01 | L05 |